Case 41-2015: A 14-Year-Old boy with immune and liver abnormalities

New England Journal of Medicine

Volumn 373, Issue 27, 2015, Pages 2664-2676

  Walter, Jolan E ^a   Armanios, Mary ^a   Shah, Uzma ^c   Friedmann, Alison M ^b   Spitzer, Thomas ^c   Sharatz, Steven M ^d   Hagen, Catherine ^a  

^a Division of Pediatric Allergy Immunology   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BRAIN; CASE REPORT; CLINICAL OBSERVATION; CLINICAL STUDY; COMPLICATION; DIAGNOSIS; DYSKERATOSIS CONGENITA; FEMALE; HUMAN; IMMUNOLOGIC DEFICIENCY SYNDROMES; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING DISORDER; LIVER; LIVER FUNCTION TEST; MALE; PATHOLOGY; PEDIGREE; TELOMERE;

ADOLESCENT; BRAIN; DIABETES MELLITUS, TYPE 1; DYSKERATOSIS CONGENITA; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LEARNING DISORDERS; LIVER; LIVER FUNCTION TESTS; MALE; PEDIGREE; TELOMERE;

EID: 84952887856     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1408595     Document Type: Conference Paper

References (45)

1. Warnatz K, Denz A, Dr.ger R, et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-51
2. Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 2009; 145: 709-27
3. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119: 1650-7
4. Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100: 731-7
5. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20
6. Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006; 116: 1713-22
7. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 2007; 120: 744-50
8. dHennezel E, Ben-Shoshan M, Ochs HD, et al. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 2009; 361: 1710-3
9. Gambineri E, Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003; 15: 430-5
10. Allenspach EJ, Bellodi C, Jeong D, et al. Common variable immunodeficiency as the initial presentation of dyskeratosis congenita. J Allergy Clin Immunol 2013; 132: 223-6
11. Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol 2000; 110: 768-79
12. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet 2012; 13: 693-704
13. Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol 1999; 107: 335-9
14. Knudson M, Kulkarni S, Ballas ZK, Bessler M, Goldman F. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood 2005; 105: 682-8
15. Slder B, Weiss M, J.ger A, Belohradsky BH. Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects: a review of the literature. Clin Pediatr (Phila) 1998; 37: 521-30
16. Slder B, Weiss M, J.ger A, Belohradsky BH. Dyskeratosis congenita: genetic hematologic-immunologic systemic disease with pancytopenia. Klin Padiatr 1996; 208: 344-9. (In German.)
17. Alder JK, Parry EM, Yegnasubramanian S, et al. Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene. Hum Mutat 2013; 34: 1481-5
18. Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I. A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK-SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome. Br J Haematol 2002; 119: 765-8
19. Sznajer Y, Baumann C, David A, et al. Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr 2003; 162: 863-7
20. Jyonouchi S, Forbes L, Ruchelli E, Sullivan KE. Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum-A single-center pediatric experience. Pediatr Allergy Immunol 2011; 22: 313-9
21. Wiedemann HP, McGuire J, Dwyer JM, et al. Progressive immune failure in dyskeratosis congenita: report of an adult in whom Pneumocystis carinii and fatal disseminated candidiasis developed. Arch Intern Med 1984; 144: 397-9
22. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2, 500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-97
23. Fuss IJ, Friend J, Yang Z, et al. Nodular regenerative hyperplasia in common variable immunodeficiency. J Clin Immunol 2013; 33: 748-58
24. Calado RT, Regal JA, Kleiner DE, et al. A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One 2009; 4(11): e7926
25. Gonzlez-Huezo MS, Villela LM, Zepeda-Florencio MdelC, Carrillo-Ponce CS, Mondragn-Snchez RJ. Nodular regenerative hyperplasia associated to aplastic anemia: a case report and literature review. Ann Hepatol 2006; 5: 166-9
26. Talbot-Smith A, Syn WK, MacQuillan G, Neil D, Elias E, Ryan P. Familial idiopathic pulmonary fibrosis in association with bone marrow hypoplasia and hepatic nodular regenerative hyperplasia: a new trimorphic syndrome. Thorax 2009; 64: 440-3
27. Rocha V, Devergie A, Soci G, et al. Unusual complications after bone marrow transplantation for dyskeratosis congenita. Br J Haematol 1998; 103: 243-8
28. Armanios M. Syndromes of telomere shortening. Annu Rev Genomics Hum Genet 2009; 10: 45-61
29. Stanley SE, Armanios M. The short and long telomere syndromes: paired paradigms for molecular medicine. Curr Opin Genet Dev 2015; 33: 1-9
30. Jonassaint NL, Guo N, Califano JA, Montgomery EA, Armanios M. The gastrointestinal manifestations of telomeremediated disease. Aging Cell 2013; 12: 319-23
31. Stanley SE, Chen JJ, Podlevsky JD, et al. Telomerase mutations in smokers with severe emphysema. J Clin Invest 2015; 125: 563-70
32. Gorgy AI, Jonassaint NL, Stanley SE, et al. Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders. Chest 2015; 148: 1019-26
33. Silhan LL, Shah PD, Chambers DC, et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 2014; 44: 178-87
34. Guo N, Parry EM, Li LS, et al. Short telomeres compromise-cell signaling and survival. PLoS One 2011; 6(3): e17858
35. Alder JK, Barkauskas CE, Limjunyawong N, et al. Telomere dysfunction causes alveolar stem cell failure. Proc Natl Acad Sci U S A 2015; 112: 5099-104
36. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest 2013; 123: 996-1002
37. Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet 1999; 65: 50-8
38. Parry EM, Alder JK, Lee SS, et al. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J Med Genet 2011; 48: 327-33
39. Velazquez I, Alter BP. Androgens and liver tumors: Fanconis anemia and non-Fanconis conditions. Am J Hematol 2004; 77: 257-67
40. Rosenberg HKMR, Markowitz RI, Kolberg H, Park C, Hubbard A, Bellah RD. Normal splenic size in infants and children: sonographic measurements. AJR Am J Roentgenol 1991; 157: 119-21
41. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of hypersplenic thrombocytopenia. J Clin Invest 1966; 45: 645-57
42. Alter BP, Giri N, Savage SA, et al. Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 2010; 150: 179-88
43. Gadalla SM, Sales-Bonfim C, Carreras J, et al. Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant 2013; 19: 1238-43
44. Ayas M, Nassar A, Hamidieh AA, et al. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure. Bone Marrow Transplant 2013; 48: 1168-72
45. Stanley SE, Rao AD, Gable DL, Mc-Grath-Morrow S, Armanios M. Radiation sensitivity and radiation necrosis in the short telomere syndromes. Int J Radiat Oncol Biol Phys 2015; 93: 1115-7.